Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
ARA-290 (Cibinetide) is a synthetic 11-amino-acid peptide derived from the helix-B surface of erythropoietin (EPO), developed by Araim Pharmaceuticals. It selectively activates the innate repair receptor (IRR) for anti-inflammatory, tissue-protective, and neuroprotective signaling without stimulating erythropoiesis. ARA-290 is not FDA-approved; it has received FDA Fast Track and Orphan Drug designations for sarcoidosis-associated small fiber neuropathy and remains in clinical development as of April 2026.
1 of 10 vendors lab-verified
Verified purity per dollar — the cheapest that's actually been tested
vial · 32mg· orosresearch.com· price updated today
Lot OR-LPARA32-526-B1· tested 2026-06-03· vendor-declared ✓
$119.99✓ $3.75/mg
single-vial price — packs may be lower
vial · 16mg· ionpeptide.com· price updated today
$75.00✓ $4.69/mg
20% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· glacieraminos.shop· price updated today
$54.99✓ $5.50/mg
32% more per mg vs cheapest
single-vial price — packs may be lower
vial · 12mg· peptidetech.is· price updated today
$59.99✓ $5.00/mg
25% more per mg vs cheapest
single-vial price — packs may be lower
vial · 16mg· realpeptides.co· price updated today
$85.00✓ $5.31/mg
29% more per mg vs cheapest
single-vial price — packs may be lower
vial · 16mg· skyepeptides.com· price updated today
$84.00✓ $5.25/mg
29% more per mg vs cheapest
single-vial price — packs may be lower
vial · 15mg· biolongevitylabs.com· price updated today
$95.00✓ $6.33/mg
41% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· profoundaminos.com· price updated today
$65.00✓ $6.50/mg
42% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· simplepeptide.com· price updated today
$76.00✓ $7.60/mg
51% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· ascensionpeptides.com· price updated today
$79.99✓ $8.00/mg
53% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· peptidology.co· price updated today
$54.99$5.50/mg
single-vial price — packs may be lower
16 vendors not shown — trust grade below C, or not enough verified COA data yet. We only list sources with a C grade or better.
Best price trend
Lowest $/mg for ARA-290 · verified listings only
$3.75/mg
▼ 25% over 90d
Ion Peptide has the lowest single-vial ARA-290 price at $3.58/mg among 14 COA-verified vendors on Disclosed Labs. Bulk or multi-vial deals may be lower. That's 55% less per mg than the most expensive option.
What is the price range for ARA-290?
Research-grade ARA-290 ranges from $3.58/mg to $8.00/mg across 12 verified sources, a 55% spread per mg.
How are ARA-290 prices verified on Disclosed Labs?
Every listed vendor holds a Grade C or better trust score, computed independently from lab Certificates of Analysis — not from payments or sponsorships. Prices are scraped and fact-checked daily. Vendors cannot pay to improve their ranking.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
Dahan et al. (Molecular Medicine, 2013, PMID 24136731) conducted a blinded placebo-controlled trial of 28 days of subcutaneous ARA 290 in sarcoidosis patients with documented small nerve fiber loss; treatment improved neuropathic symptoms, increased corneal nerve fiber density on confocal microscopy, altered thermal thresholds, and improved 6-minute walk distance. Brines et al. (Molecular Medicine, 2015, PMID 25387363) reported a placebo-controlled trial of 4 mg daily SubQ ARA 290 for 28 days in type 2 diabetes: the active arm showed improvements in HbA1c, lipid profile, and PainDetect neuropathic symptom scores, with recovery of intraepidermal nerve fiber measurements versus no change on placebo. Heij et al. (2012) and additional Phase 2 work have supported the tissue-protective signal. ARA-290 has not advanced to Phase 3 registration trials and is not FDA-approved.
This platform provides informational tools only, not medical advice.
Prices verified as of July 2026. Actual prices may vary. For research use only.
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.